Chief Scientific Officer
AP
A2A Pharmaceuticals
The startup develops novel drug alternatives targeting antibiotic-resistant bacterial infections and cancer through advanced drug discovery techniques. By providing effective treatment options, the company enhances the ability of healthcare professionals to manage life-threatening diseases.
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$7MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops novel drug alternatives targeting antibiotic-resistant bacterial infections and cancer through advanced drug discovery techniques. By providing effective treatment options, the company enhances the ability of healthcare professionals to manage life-threatening diseases.